InsidersTradesSigma
Kintor Pharmaceutical Ltd. - B Stock: price and management transactions · Hong Kong · HKEX
Follow the Kintor Pharmaceutical Ltd. - B stock price and the full directors' dealings record of the company, a listed issuer based in Hong Kong. Shares are quoted on HK HK, under the authority of HKEX. Operating in the Health Care sector, Kintor Pharmaceutical Ltd. - B has recorded 20 public disclosures. Market capitalisation: €881.5m. The latest transaction was reported on 26 June 2026 (Purchase). Among the most active insiders: Tong Youzhi. All data is accessible without an account.
20
Insider Decl.
0
Thresholds
€7m
18 ops.
Buy Volume
·
0 ops.
Sell Volume
28Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 25,182 of 26,211 companies
14.1
score / 100
Value10
Quality18
FCF yld-19%
Earn yld-23%
EV/EBITDA·
ROE-84%
Gross mgn25%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 26 June 2026
Declarations20 total
250,000 shares@ €0.2315ShareXHKGHKEX:DA20260626E00073
Ideal exit: 22 Mar 2027 (T+270)
75,000 shares@ €0.26940.0021% mcap0.3% of flowShareXHKGHKEX:DA20260611E00155
Ideal exit: 6 Mar 2027 (T+270)
125,000 shares@ €0.27680.0036% mcap0.5% of flowShareXHKGHKEX:DA20260608E00336
Ideal exit: 2 Mar 2027 (T+270)
50,000 shares@ €0.28580.0015% mcap0.2% of flowShareXHKGHKEX:DA20260608E00319
Ideal exit: 1 Mar 2027 (T+270)
190,000 shares@ €0.24430.0048% mcap0.7% of flowShareXHKGHKEX:DA20260528E00212
Ideal exit: 22 Feb 2027 (T+270)
110,000 shares@ €0.27140.0031% mcap0.5% of flowShareXHKGHKEX:DA20260528E00199
Ideal exit: 20 Feb 2027 (T+270)
42,000 shares@ €0.2560.0011% mcap0.2% of flowShareXHKGHKEX:DA20260528E00204
Ideal exit: 21 Feb 2027 (T+270)
38,000 shares@ €0.290.0011% mcap0.2% of flowShareXHKGHKEX:DA20260522E00299
Ideal exit: 15 Feb 2027 (T+270)
70,000 shares@ €24.90960.18% mcap27.1% of flowShareXHKGHKEX:DA20260520E00152
Ideal exit: 13 Feb 2027 (T+270)
170,000 shares@ €25.55480.45% mcap67.6% of flowShareXHKGHKEX:DA20260519E00135
Ideal exit: 12 Feb 2027 (T+270)
80,000 shares@ €0.31230.023% mcap0.4% of flowShareXHKGHKEX:DA20260511E00237
Ideal exit: 2 Feb 2027 (T+270)
28,000 shares@ €0.2880.0075% mcap0.1% of flowShareXHKGHKEX:DA20260427E00032
Ideal exit: 19 Jan 2027 (T+270)
48,000 shares@ €0.29550.013% mcap0.2% of flowShareXHKGHKEX:DA20260422E00263
Ideal exit: 16 Jan 2027 (T+270)
10,000 shares@ €0.2980.0028% mcap0.0% of flowShareXHKGHKEX:DA20260420E00094
Ideal exit: 12 Jan 2027 (T+270)
290,000 shares@ €0.29880.080% mcap1.3% of flowShareXHKGHKEX:DA20260417E00334
Ideal exit: 11 Jan 2027 (T+270)
50,000 shares@ €0.28820.0016% mcap7.5% of flowShareXHKGHKEX:DA20260410E00214
Ideal exit: 4 Jan 2027 (T+270)
65,000 shares@ €0.29560.0021% mcap10.1% of flowShareXHKGHKEX:DA20260409E00109
Ideal exit: 3 Jan 2027 (T+270)
71,500 shares@ €0.28680.0022% mcap10.7% of flowShareXHKGHKEX:DA20260407E00049
Ideal exit: 28 Dec 2026 (T+270)
1,250,000 sharesShareXHKGHKEX:DA20260401E00085
20 of 20 declarations
About Kintor Pharmaceutical Ltd. - B
Kintor Pharmaceutical Ltd. is a biopharmaceutical company focused on developing innovative treatments for serious diseases. It is listed on the Hong Kong Stock Exchange.